Table 2 Descriptive analysis of clinical evaluations according to the phases of the study
Variables | Subsample (n = 30) | Sample (n = 225) |
|---|---|---|
KPS (score) | 60.00 (12.86) | 61.46 (16.47) |
PPI (score) | 2.96 (1.83) | 2.33 (1.89) |
ESAS (score) | ||
Pain | 4.83 (3.17) | 3.76 (3.13) |
Tiredness | 4.20 (3.37) | 3.32 (2.83) |
Nausea | 3.06 (3.20) | 3.24 (2.99) |
Sadness | 5.90 (3.57) | 5.34 (3.07) |
Anxiety | 6.83 (3.20) | 6.13 (3.14) |
Somnolence | 4.36 (2.73) | 4.04 (2.76) |
Appetite | 4.26 (2.59) | 3.72 (2.48) |
Welfare | 4.93 (2.27) | 3.73 (2.20) |
Dyspnea | 3.40 (3.73) | 1.95 (2.59) |
Barthel Index (score) | 70.33 (22.39) | 72.39 (19.92) |
MQOL (score) | ||
Physical symptoms | 3.83 (1.88) | 4.90 (4.63) |
Physical well-being | 4.76 (1.86) | 5.55 (2.64) |
Psychological | 2.85 (1.31) | 4.20 (2.18) |
Existential | 4.71 (1.54) | 5.40 (1.91) |
Support | 6.76 (1.38) | 7.05 (1.91) |
EORTC-QLQ-C15-PAL (score) | ||
Functional | 60.66 (24.15) | 44.44 (25.27) |
Symptoms | 44.44 (19.98) | 36.88 (20.33) |
Quality of life | 45.00 (25.94) | 55.33 (28.80) |